John J. Cush

10.9k citations
58 papers · 4.3k · 3 hit papers · h-index 31

Impact in

  • Rheumatology top 0.2%
    • Rheumatoid Arthritis Research and Therapies
    • Spondyloarthritis Studies and Treatments
    • Systemic Lupus Erythematosus Research
  • Hematology top 1%
    • Autoimmune and Inflammatory Disorders Research

Papers in

    • Rheumatoid Arthritis Research and Therapies 27
    • Systemic Lupus Erythematosus Research 14
    • Spondyloarthritis Studies and Treatments 4
    • Autoimmune and Inflammatory Disorders Research 12

John J. Cush

57 papers receiving 4.1k citations

John J. Cush's Hit Papers

Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis 2012 · 801 citations
8010+8+16Years since publication250500750

Peers

John J. Cush
Comparison fields: 5 of 108
  • Rheumatology 2.3k
  • Hematology 677
  • Immunology 1.1k
  • Immunology and Allergy 159
  • Genetics 223
Replace Diego Kyburz with:
Diego Kyburz Switzerland
Dae‐Hyun Yoo South Korea
Thomas Barnetche France
Motomu Hashimoto Japan
Prodromos Sidiropoulos Greece
Diane van der Woude Netherlands
Kimberly L. DeWoody United States
Peter Junker Denmark
Raimón Sanmartí Spain
Pilar Barrera Netherlands
John J. Cush relative to Diego Kyburz Switzerland Diego Kyburz's profile →
Citations per field
00.5×1.5×
Diego Kyburz · 1×
Citations per year

Countries citing papers authored by John J. Cush

Since Specialization
Citations

This map shows the geographic impact of John J. Cush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Cush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Cush more than expected).

Fields of papers citing papers by John J. Cush

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Cush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Cush. The network helps show where John J. Cush may publish in the future.

Co-authors

The 25 scholars most cited alongside John J. Cush, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John J. Cush Line = papers co-authored together John J. Cush links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Hit paper breakdown →
2012801
2
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial
Hit paper breakdown →
2003586
3
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: Results of a twenty‐four–week, multicenter, randomized, double‐blind, placebo‐controlled trial
Hit paper breakdown →
2002500
4 1995218
5 1988215
6 2013141
7
A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis.
2001126
8 2018120
9
Early rheumatoid arthritis -- is there a window of opportunity?
2007108
10
The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis.
200495
11 202194
12 199385
13 202282
14 202174
15 199173
16 201562
17 201262
18 201461
19
Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept.
200558
20 199254

About John J. Cush

John J. Cush is a scholar working on Rheumatology, Hematology, Immunology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging, having authored 58 papers that have together received 4.3k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (27 papers), Systemic Lupus Erythematosus Research (14 papers), Autoimmune and Inflammatory Disorders Research (12 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Pregnancy and Medication Impact (8 papers), Spondyloarthritis Studies and Treatments (4 papers), Biosimilars and Bioanalytical Methods (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Rheumatology (2.3k citations), Hematology (677 citations), Immunology (1.1k citations), Immunology and Allergy (159 citations) and Genetics (223 citations). John J. Cush has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Peter E. Lipsky, Roy Fleischmann, Joel M. Kremer, Hendrik Schulze‐Koops, Samuel H. Zwillich, Keith S. Kanik, Carol A. Connell, John Bradley, David Gruben and Gene V. Wallenstein. Their work appears in journals such as Rheumatic Disease Clinics of North America, The Journal of Rheumatology, Arthritis Care & Research, The American Journal of Medicine and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact